You're listening to Plenary Session.

This week on Plenary Session, we have a few things in store for you.

First, I'm joined in the studio with Dr. Sven Olson.

Dr. Olson is the chief fellow of hematology oncology at OHSU,

and he's going to take us through

a paper entitled, a Phase 3 randomized trial of Vauxellator in sickle cell disease.

This drug has a great name Vauxellator, but is this data ready for U.S. Food and Drug Administration

accelerated approval?

Question mark.

We're going to talk about that on this week's episode.

Next, I have a far-reaching

interview with none other than david steinsma dr steinsma from the dfc i came out here to

portland organ delivered a fantastic grand rounds and sat down with us in the plenary session studio

for a nearly two-hour interview we talk talk about many topics, and I think you're

going to find this of great interest. So, stay tuned. But first, a plug. If you like this episode

and you like this podcast, I need you to do three things. One, go to patreon.com and back

this podcast. Backing an artist you support on patreon.com is a great way to keep something going.

Next, go to the iTunes store and don't just give us five stars. Write a review. Tell us what you

like about the podcast and what you don't like. A written review goes a long way.

Third, recommend Plenary Session to a friend.

If you have a friend, a colleague, someone you think is going to like this podcast, give

them a recommendation.

...